EFFECT OF HYPERPRODUCTION OF TEM-1 BETA-LACTAMASE ON IN-VITRO SUSCEPTIBILITY OF ESCHERICHIA-COLI TO BETA-LACTAM ANTIBIOTICS

被引:65
作者
WU, PJ [1 ]
SHANNON, K [1 ]
PHILLIPS, I [1 ]
机构
[1] UNITED MED & DENT SCH, ST THOMAS HOSP, DEPT MICROBIOL, LONDON SE1 7EH, ENGLAND
关键词
D O I
10.1128/AAC.38.3.494
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The susceptibility of 173 TEM-1-producing isolates of Escherichia coli was assessed by determination of MICs by the agar dilution method. MICs of amoxicillin, mezlocillin, cephaloridine, and, to a smaller extent, amoxicillin-clavulanic acid (but not cephalexin, cefuroxime, cefotaxime, ceftazidime, or imipenem) were higher for isolates that produced large amounts of beta-lactamase than for isolates that produced smaller amounts. The effect of fixed concentrations of clavulanic acid on resistance-to amoxicillin was assessed for 34 selected TEM-l-producing isolates. Low concentrations of the inhibitor (0.5 to 1 mu g/ml) reduced the amoxicillin MICs substantially for almost all the isolates, although the reductions were not sufficient to render any of the isolates amoxicillin susceptible.]Higher concentrations of clavulanic acid had progressively greater effects on amoxicillin MICs, but even at 8 mu g/ml some of the isolates with high beta-lactamase activities remained resistant or only moderately susceptible to amoxicillin. All the isolates were inhibited by clavulanic acid (in the absence of amoxicillin) at concentrations of 16 to 32 mu g/ml. TEM-1 beta-lactamase activity was inhibited in vitro by clavulanic acid, but not totally, with approximately 2% of the initial activity remaining at 2 mu g/ml and 0.4% remaining at 8 mu g/ml. These findings suggest that the amount of beta-lactamase activity is a major determinant of the degree of resistance to several beta-lactam antibiotics and can make the difference between susceptibility and resistance to some compounds, notably the combination of amoxicillin with clavulanic acid.
引用
收藏
页码:494 / 498
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 1991, J ANTIMICROB CHEM SD, V27, P1
[2]   CHARACTERIZATION OF A NEW TEM-TYPE BETA-LACTAMASE RESISTANT TO CLAVULANATE, SULBACTAM, AND TAZOBACTAM IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
BLAZQUEZ, J ;
BAQUERO, MR ;
CANTON, R ;
ALOS, I ;
BAQUERO, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (10) :2059-2063
[3]  
FRENCH G, 1988, LANCET, V1, P704
[4]   CALCULATING MIC50 [J].
HAMILTONMILLER, JMT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 27 (06) :863-864
[5]  
Herbert D., 1971, METHODS MICROBIOLO B, V5B, P244
[6]   MORE EXTENDED-SPECTRUM BETA-LACTAMASES [J].
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (09) :1697-1704
[7]  
LABIA R, 1979, BETA LACTAMASES, P429
[8]   INVITRO SUSCEPTIBILITY OF NOSOCOMIAL GRAM-NEGATIVE BLOOD-STREAM PATHOGENS TO QUINOLONES AND OTHER ANTIBIOTICS - A STATISTICAL APPROACH [J].
MARTIN, MA ;
PFALLER, MA ;
ROJAS, PB ;
WOOLSON, RF ;
WENZEL, RP .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (03) :353-361
[9]  
MARTINEZ JL, 1987, LANCET, V2, P473
[10]   HYPERPRODUCTION OF TEM-1 BETA-LACTAMASE BY ESCHERICHIA-COLI STRAINS [J].
PAGE, JWJ ;
FARMER, TH ;
ELSON, SW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 23 (01) :160-161